SENATE DOCKET, NO. 270        FILED ON: 1/13/2017

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1099

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

John F. Keenan

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to patient choice to promote prescription safety.

_______________

PETITION OF:

 

Name:

District/Address:

 

John F. Keenan

Norfolk and Plymouth

 

James M. Cantwell

4th Plymouth

1/27/2017

Smitty Pignatelli

4th Berkshire

2/1/2017

Mathew Muratore

1st Plymouth

2/1/2017


SENATE DOCKET, NO. 270        FILED ON: 1/13/2017

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1099

By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1099) of John F. Keenan, James M. Cantwell, William Smitty Pignatelli and Mathew Muratore for legislation relative to patient choice to promote prescription safety.  Mental Health, Substance Use and Recovery.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act relative to patient choice to promote prescription safety.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 18 of said chapter 94C is hereby amended by striking subsection (d¾) as inserted by section 21 of chapter 52 of the acts of 2016, and inserting in place thereof the following subsection:-

(d¾) A registered pharmacist filling a prescription for an opioid substance in schedule II of section 3 shall, if requested by the patient, dispense the prescribed substance in a lesser quantity than indicated on the prescription. Within a reasonable time following a reduction in quantity, but not to exceed 7 days, the pharmacist or a designee shall notify the prescribing practitioner of the reduction and of the amount actually dispensed.  The notification shall be conveyed by a notation in the interoperable electronic health record of the patient as defined by section 1 of chapter 118I or, if the pharmacist does not have the ability to make a notation in the patient’s interoperable electronic health record, by facsimile or electronic transmission to the prescribing practitioner. A prescription filled in a lesser quantity pursuant to this subsection shall be considered a partial fill and the remaining portion may be filled according to federal regulations applicable to partially filled prescriptions; provided, however, that the fill of the remaining portion shall occur at the pharmacy that initially dispensed the partial fill. Nothing in this subsection shall be interpreted to conflict with or supersede any other requirement established in this section for a prescription of a narcotic substance or any requirements or conditions for drug substitutions established in chapter 112. 

SECTION 2. The second paragraph of section 21A of said chapter 94C, as appearing in the 2014 Official Edition, is hereby amended by adding the following sentence:- A pharmacist or a pharmacist’s designee shall notify  any person who presents for filling a prescription for an opiate contained in schedule II of section 3 that the person may choose to receive a lesser quantity of the prescribed substance than the quantity indicated on the prescription in accordance with subsection (d3/4) of section 18.

SECTION 3. Section 22 of said chapter 94C, as amended by chapter 52 of the acts of 2016, is hereby further amended by striking, in subsection (c), the words “recommended full quantity indicated” and inserting in place thereof the words:- “full prescribed quantity”

SECTION 4.  Chapter 175 of the General Laws, as amended by chapter 233 of the acts of 2016, is hereby amended by inserting after section 47II the following section:-

Section 47JJ.  Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth, which is considered creditable coverage under section 1 of chapter 111M, shall provide, for any covered drug that is a narcotic substance contained in schedule II of section 3 of chapter 94C and that is subject to cost sharing, a schedule that allows for adjustments and reductions in the cost sharing when a person requests a prescription filled in a lesser quantity pursuant to section 18 of said chapter 94C.

SECTION 5.  Chapter 176A of the General Laws, as amended by chapter 233 of the acts of 2016, is hereby amended by inserting after section 8KK the following section:-

Section 8LL.  Any contract between a subscriber and the corporation under an individual or group hospital service plan which is delivered, issued or renewed within the commonwealth shall provide, for any covered drug that is a narcotic substance contained in schedule II of section 3 of chapter 94C and that is subject to cost sharing, a schedule that allows for adjustments and reductions in the cost sharing when a person requests a prescription filled in a lesser quantity pursuant to section 18 of said chapter 94C.

SECTION 6.  Chapter 176B of the General Laws, as amended by chapter 233 of the acts of 2016, is hereby amended by inserting after section 4KK the following section:-

Section 4LL.  Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide, for any covered drug that is a narcotic substance contained in schedule II of section 3 of chapter 94C and that is subject to cost sharing, a schedule that allows for adjustments and reductions in the cost sharing when a person requests a prescription filled in a lesser quantity pursuant to section 18 of said chapter 94C.

SECTION 7.  Chapter 176G of the General Laws, as amended by chapter 233 of the acts of 2016, is hereby amended by inserting after section 4CC the following section:-

Section 4DD.  An individual or group health maintenance contract that is issued or renewed shall provide, for any covered drug that is a narcotic substance contained in schedule II of section 3 of chapter 94C and that is subject to cost sharing, a schedule that allows for adjustments and reductions in the cost sharing when a person requests a prescription filled in a lesser quantity pursuant to section 18 of said chapter 94C.